Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 5/20 | 0.42 |
| ▸ | GALR3 | O60755 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PRKCB | P05771 | 1/20 | 0.40 |
| ▸ | BRAF | P15056 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4768406 | 0.95 | HRH3 (0.46) | HRH3GALR3LMNATSHRHTT | |
| Trifluoroacetic Acid SCHEMBL4772057 | 0.85 | POLB (0.47) | SLC2A1HRH3ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL4767967 | 0.82 | HRH3 (0.48) | HRH3LMNAALDH1A1BACE1HRH1 | |
| Trifluoroacetic Acid SCHEMBL4766836 | 0.81 | SLC2A1 (0.44) | SLC2A1HRH3LMNAALDH1A1CYP3A4 | |
| Trifluoroacetic Acid SCHEMBL4764951 | 0.81 | HRH3 (0.47) | SLC2A1HRH3LMNAHTTALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL4770476 | 0.80 | SLC2A1 (0.43) | SLC2A1HRH3LMNAALDH1A1POLB | |
| Trifluoroacetic Acid SCHEMBL4774899 | 0.80 | SLC2A1 (0.43) | SLC2A1HRH3HRH1 | |
| Trifluoroacetic Acid SCHEMBL4775487 | 0.79 | KMT2A (0.53) | SLC2A1LMNATSHRALDH1A1HSD17B10 | |
| Trifluoroacetic Acid SCHEMBL4768548 | 0.79 | ALDH1A1 (0.64) | SLC2A1HRH3LMNAHTTALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL4770952 | 0.79 | LMNA (0.51) | SLC2A1HRH3LMNAHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | claimed |
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | GLAXO GROUP LIMITED (GB) | 2007-03-15 | — | — | US | claimed |
| EP-1713778-B1 | BENZAZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS | GLAXO GROUP LTD (GB) | 2008-01-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070060566-A1 | Benzazepine derivatives as histamine h3 antagonists | HRH3, HRH4, HRH1 | SLC2A1 4665/4885HRH3 1/4885GALR3 537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.